Health And Medicine
-
Vanderbilt study finds no heart risk in ADHD medications
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. Read MoreNov 2, 2011
-
Lung disorder drug regimen found harmful
Longtime treatment for IPF ineffective and even dangerous. Read MoreOct 31, 2011
-
Protein family key to aging linked to suppressing tumors
The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health. Read MoreOct 28, 2011
-
Vanderbilt doctors to screen patients taking statins for genetic risk factors
Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. Read MoreOct 28, 2011
-
Stopping colitis, STAT
Study suggests a new therapeutic target in ulcerative colitis. Read MoreOct 27, 2011
-
Growth factor boosts beta cells
A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read MoreOct 21, 2011
-
Information flow reduced in psychosis
Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows. Read MoreOct 21, 2011
-
Initiative to help ‘translate’ diabetes research advances
The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read MoreOct 21, 2011
-
Predicting hospital readmission is risky business: study
Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers. Read MoreOct 18, 2011
-
Supplements don’t help lung injury patients
Supplements did not improve outcomes of patients with acute lung injury. Read MoreOct 13, 2011
-
Diversity key in antibody repertoire
Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read MoreOct 7, 2011
-
Fungus toxin gets in the way in DNA
Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development. Read MoreOct 7, 2011
-
Heart protein may be target for colon cancer therapies
A protein critical in heart development may also play a part in colon cancer progression. Read MoreOct 7, 2011
-
Parkinson’s deep brain target fired up
Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests. Read MoreOct 5, 2011
-
Drug-like molecules aimed at improving treatment of Parkinson’s
Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read MoreSep 30, 2011
-
Folate may lower breast cancer risk for some
Low folate levels may increase a premenopausal woman’s risk of developing breast cancer. Read MoreSep 29, 2011
-
Study puts a new spin on ibuprofen’s actions
Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs. Read MoreSep 29, 2011
-
New study confirms safety of eight vaccines
A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism. Read MoreSep 28, 2011
-
Examining the ethics of sharing genetic risk information
Should scientists inform participants in genomic studies about their risk for diseases or conditions discovered during the studies, and if so, when and how? A Vanderbilt professor is part of a team working to answer these questions. Read MoreSep 28, 2011
-
Interactive brain exhibit opens at Vanderbilt Health One Hundred Oaks
A state-of-the-art interactive exhibit on the brain and brain research has opened at Vanderbilt Health One Hundred Oaks. Read MoreSep 27, 2011